- Home
- MESA vs PRLD Comparison
MESA vs PRLD Comparison
Compare MESA & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- PRLD
- Stock Information
- Founded
- MESA 1982
- PRLD 2016
- Country
- MESA United States
- PRLD United States
- Employees
- MESA N/A
- PRLD N/A
- Industry
- MESA Air Freight/Delivery Services
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- MESA Consumer Discretionary
- PRLD Health Care
- Exchange
- MESA Nasdaq
- PRLD Nasdaq
- Market Cap
- MESA 59.5M
- PRLD 69.1M
- IPO Year
- MESA 2018
- PRLD 2020
- Fundamental
- Price
- MESA $1.66
- PRLD $1.48
- Analyst Decision
- MESA
- PRLD Strong Buy
- Analyst Count
- MESA 0
- PRLD 3
- Target Price
- MESA N/A
- PRLD $4.00
- AVG Volume (30 Days)
- MESA 168.9K
- PRLD 3.4M
- Earning Date
- MESA 12-19-2025
- PRLD 11-12-2025
- Dividend Yield
- MESA N/A
- PRLD N/A
- EPS Growth
- MESA N/A
- PRLD N/A
- EPS
- MESA N/A
- PRLD N/A
- Revenue
- MESA $406,021,000.00
- PRLD $10,500,000.00
- Revenue This Year
- MESA $39.81
- PRLD N/A
- Revenue Next Year
- MESA N/A
- PRLD N/A
- P/E Ratio
- MESA N/A
- PRLD N/A
- Revenue Growth
- MESA N/A
- PRLD 250.00
- 52 Week Low
- MESA $0.68
- PRLD $0.61
- 52 Week High
- MESA $1.72
- PRLD $4.22
- Technical
- Relative Strength Index (RSI)
- MESA 64.12
- PRLD 49.72
- Support Level
- MESA $1.41
- PRLD $1.17
- Resistance Level
- MESA $1.72
- PRLD $1.62
- Average True Range (ATR)
- MESA 0.11
- PRLD 0.37
- MACD
- MESA 0.02
- PRLD -0.04
- Stochastic Oscillator
- MESA 83.25
- PRLD 10.84
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.